-
Start Preamble
Start Printed Page 26392
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Proposed rule; correction.
SUMMARY:
The Food and Drug Administration is correcting a proposed rule to amend its regulations concerning the classification of products as biological products, devices, drugs, or combination products, and their assignment to Agency components for premarket review and regulation that appeared in the Federal Register of May 15, 2018. The document was published with an error in the discussion of the preliminary economic analysis impact. This document corrects that error.
DATES:
Submit either electronic or written comments on the proposed rule by July 16, 2018.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Melissa Burns, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5129, Silver Spring, MD 20933, 301-796-8930, melissa.burns@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In the Federal Register of Tuesday, May 15, 2018, beginning on page 22428 for FR Doc. 2018-10321, table 1 on page 22433 is corrected to read:
Start SignatureTable 1—Benefits, Costs, and Distributional Effects of the Proposed Rule 1 2
Category Primary estimate Low estimate High estimate Units Notes Year dollars Discount rate (%) Period covered (years) Costs: Annualized $17,000 $12,000 $27,000 2016 7 10 Monetized $/year 15,000 10,000 23,000 2016 3 10 Annualized 7 Quantified 3 Qualitative Benefits: Annualized 28,000 25,000 89,000 2016 7 10 Monetized $/year 28,000 25,000 89,000 2016 3 10 Annualized 7 Quantified 3 Qualitative Firms and FDA may realize savings from sponsors choosing to submit electronic RFDs Transfers: Federal 7 Annualized Monetized $millions/year 3 From/To From: To: Other 7 Annualized Monetized $millions/year 3 From/To From: To: Effects: State, Local or Tribal Government: Small Business: Will not have a significant impact on a substantial number of small entities. Wages: Growth: 1 We use a 10-year time horizon for this rule with payments occurring at the end of each period. 2 All dollar values are rounded to the nearest $1,000. Dated: June 1, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-12201 Filed 6-6-18; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 06/07/2018
- Department:
- Food and Drug Administration
- Entry Type:
- Proposed Rule
- Action:
- Proposed rule; correction.
- Document Number:
- 2018-12201
- Dates:
- Submit either electronic or written comments on the proposed rule by July 16, 2018.
- Pages:
- 26392-26392 (1 pages)
- Docket Numbers:
- Docket No. FDA-2004-N-0191
- PDF File:
- 2018-12201.pdf
- CFR: (1)
- 21 CFR 3